|
|
Volumn 2, Issue 2, 2001, Pages 110-112
|
|
Randomized phase II trial comparing exemestane to tamoxifen for first-line hormonal therapy of postmenopausal patients with metastatic breast cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN B;
EXEMESTANE;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LIPID;
TAMOXIFEN;
TRIACYLGLYCEROL;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
CANCER HORMONE THERAPY;
CHOLESTEROL BLOOD LEVEL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DYSPNEA;
EDEMA;
FEMALE;
HOT FLUSH;
HUMAN;
LIPID BLOOD LEVEL;
LIPOPROTEIN BLOOD LEVEL;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
METASTASIS;
NAUSEA;
PAIN;
PHASE 2 CLINICAL TRIAL;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL;
TRIACYLGLYCEROL BLOOD LEVEL;
WEIGHT GAIN;
|
|
EID: 0034892899
PISSN: 15268209
EISSN: None
Source Type: Journal
DOI: 10.1016/S1526-8209(11)70304-4 Document Type: Article |
|
Times cited : (2)
|
|
References (8)
|
